Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

Date
2019
Author
Dragomir, Monica
Kitanovski, Lidija
von Bueren, Andre O.
Rutkauskiene, Giedre
Calvagna, Victor
Drogosiewicz, Monika
Deak, Ladislav
Kramm, Christof M.
El-Khouly, Fatma E.
van Zanten, Sophie E. M. Veldhuijzen
Santa-Maria Lopez, Vicente
Hendrikse, N. Harry
Kaspers, Gertjan J. L.
Loizos, G.
Sumerauer, David
Nysom, Karsten
Pruunsild, Kaie
Pentikainen, Virve
KEBUDİ, Rejin
Thorarinsdottir, Halldora K.
Janssens, Geert O. R.
Thomale, Ulrich W.
Hayden, Tim
Bailey, Simon
Holm, Stefan
Cruz-Martinez, Ofelia
Kumirova, Ella
Gil-da-Costa, Maria Joao
Torsvik, Ingrid K.
Lopez Aguilar, Enrique
Massimino, Maura
Biassoni, Veronica
Pears, Jane
Hauser, Peter
Kattamis, Antonis
Grill, Jacques
Entz-Werle, Natacha
Jadrijevic-Cvrlje, Filip
van Vuurden, Dannis G.
Jacobs, Sandra
Slavc, Irene
Metadata
Show full item record
Abstract
Introduction Diffuse intrinsic pontine glioma (DIPG) is a rare clinically, neuro-radiologically, and molecularly defined malignancy of the brainstem with a median overall survival of approximately 11 months. Our aim is to evaluate the current tendency for its treatment in Europe in order to develop (inter)national consensus guidelines.
URI
http://hdl.handle.net/20.500.12627/175238
https://doi.org/10.1007/s11060-019-03287-9
https://avesis.istanbul.edu.tr/api/publication/e8ef034d-b8e8-4324-a820-0d594f8f716c/file
Collections